Skip to main content
OpenTrials
Completed

NCT Number: NCT00999232

Assess the Effect of Erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube

The purpose of this study is to assess the effect of erythromycin on the Rate of Success in Placement of a Self-propelled Feeding Tube.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Aged 18-80 years
  • Having pancreatitis
  • Require jejunal enteral nutrition

Exclusion criteria

  • Known impaired peristalsis (critically ill patients, postoperative patients, history of surgery of the stomach/duodenum)
  • Pregnancy
  • Hypersensibility to erythromycin
  • Cardiac arrhythmias with a prolonged QT-time
  • Simultaneous usage of drugs impairing peristalsis

Treatment and study plan

Erythromycin

Drug

Subjects receive 4x250mg erythromycin i.v. daily after intubation of a self-propelled feeding tube

Placebo

Drug

Subjects receive 4x placebo i.v. daily after intubation of a self-propelled feeding tube

Primary outcomes

  1. The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 48 hours.

Secondary outcomes

  1. The success rate of spontaneous positioning the tubes tip into the jejunum, beyond Treitz ligament, after 24 hours.

  2. Adverse events using this self-propelled tube

Sponsors and collaborators

Lead sponsor

Canisius-Wilhelmina Hospital

Other

Registry information

Important dates

Study start
2004
Primary completion
2007
First posted
Oct 21, 2009
Registry last updated
Jan 22, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.